Lack of correlation between phenotype and genotype for the polymorphically expressed dihydropyrimidine dehydrogenase in a family of Pakistani origin

Pharmacogenetics

Volumn 7, Issue 2, 1997, Pages 161-163

  Fernandez Salguero, Pedro M ^a   Sapone, Andrea ^a   Wei, Xiaoxiong ^a   Holt, John R ^b   Jones, Steve ^c   Idle, Jeffrey R ^b   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Institute for Cancer Research   (Norway)

^c PINDERFIELDS GENERAL HOSPITAL   (United Kingdom)

Author keywords

DPD; Human polymorphism; Splice mutation; Thymine uraciluria

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; THYMINE; URACIL;

ALLELE; ARTICLE; CASE REPORT; CONVULSION; DEVELOPMENTAL DISORDER; ENZYME DEFICIENCY; GENE MUTATION; GENETIC POLYMORPHISM; HIGH RISK PATIENT; HUMAN; INBORN ERROR OF METABOLISM; MALE; PAKISTAN; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PYRIMIDINE METABOLISM; SEQUENCE TAGGED SITE;

CHILD, PRESCHOOL; DIHYDROURACIL DEHYDROGENASE (NADP); GENOTYPE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; OXIDOREDUCTASES; PAKISTAN; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PURINE-PYRIMIDINE METABOLISM, INBORN ERRORS; RNA SPLICING; SEQUENCE TAGGED SITES; THYMINE; URACIL;

RAPHIA FRATER;

EID: 0030946626     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199704000-00012     Document Type: Article

References (12)

1. Bakkeren JAJM, De Abreu RA, Sengers RCA, Gabreels FJM, Maas JM, Renier WO. Elevated urine, blood and cerebrospinal fluid levels of uracil and thymine in a child with dihydropyrimidine dehydrogenase deficiency. Clin Chim Acta 1984: 140, 247-256.
2. Berger R, Stoker-De Vries SA, Wadman SK, Duran M, Beeemer FA, De Bree PK, Weits-Binnerts JJ, Penders TJ, Van Der Woude JK. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism. Clin Chim Acta 1984: 141, 227-234.
3. Braakhekke JP, Renier WO, Gabreels FJM, De Abreu RA, Bakkeren JAJM, Sengers RCA. Dihydropyrimidine dehydrogenase deficiency. Neurological aspects. J Neurol Sci 1987: 78, 71-77.
4. De Abreu RA, Bakkeren JAJM, Braakhekke J, Gabreels FJM, Maas JM, Sengers RCA. Dihydrothymine dehydrogenase deficiency in a family leading to elevated levels of uracil and thymine. Adv Exp Med Biol 1986: 195A, 77-80.
5. Fernandez-Salguero P, Gonzalez FJ, Etienne MC, Milano G, Kimura S. Correlation between catalytic activity and protein content for the polymorphically expressed dihydropyrimidine dehydrogenase in human lymphocytes. Biochem Pharmacol 1995: 50, 1015-1020.
6. Gonzalez FJ, Fernandez-Salguero P. Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency. Trends Pharmacol Sci 1995: 16, 325-327.
7. Meinsma R, Fernandez-Salguero P, van Kuilenburg AB, van Gennip AH, Gonzalez FJ. Human polymorphism in drug metabolism: mutation in the dihydropyrimidine dehydrogenase gene results in exon skipping and thymine uracilurea. DNA Cell Biol 1995: 14, 1-6.
8. Milano G, Etienne MC. Potential importance of dihydropyrimidine dehydrogenase (DPD) in cancer chemotherapy. Pharmacogenetics 1994: 4, 301-306.
9. Takai S, Fernandez-Salguero P, Kimura S, Gonzalez FJ, Yamada K. Assignment of the human dihydropyrimidine dehydrogenase gene (DPYD) to chromosome region Ip22 by fluorescence in situ hybridization. Genomics 1994: 24, 613-614.
10. Vreken P, Van Kuilenburg ABP, Meinsma R, Smit GPA, Bakker HD, De Abreu RA, van Gennip AH. A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis 1996: 19, 645-654.
11. Wadman SK, Berger R, Duran M, De Bree PK, Stoker-de Vries SA, Beemer FA, Weits-Binnerts JJ, Penders TJ, Van Der Woude JK. Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism. J Inherited Metab Dis 1985: 8, 113-114.
12. Wei X, McLeod HL, McMurrough J, Gonzalez FJ, Fernandez-Salguero P. Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity. J Clin Invetigation 1996: 98, 610-615.